Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is POLYMYXIN B SULFATE, with a corresponding US DMF Number 22030.
Remarkably, this DMF maintains an Active status since its submission on October 01, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 20, 2013, and payment made on November 08, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II